You are here: Home Newsroom News Boots launches new COVID-19 lateral flow tests as government announces plans to limit free testing

Boots launches new COVID-19 lateral flow tests as government announces plans to limit free testing

22 February 2022
News Healthcare
  • Boots will launch a COVID-19 lateral flow test available to buy in storeswith prices from £2.50 per test  

  • Boots will also offer a lateral flow test for £5.99 per test or £17 for a pack of four including delivery, available on from tomorrow. These tests will offer customers the option to send results to the UK Health Security Agency if needed 

Following the government’s announcement to limit free COVID-19 testing from 1st April, Boots has announced it will launch affordable COVID-19 lateral flow tests in its stores and online, for asymptomatic testing.  

From tomorrow, customers can purchase a pack of four lateral flow tests for £17, or one test for £5.99, from, with both options including delivery. This test will offer customers an option to send their results to the UK Health Security Agency (UKHSA) to report a negative test, should customers need it.* 

From early March, the health and beauty retailer will also offer lateral flow tests at over 400 Boots stores, priced at just £2.50 for a single test or £12 for a pack of five. These tests will also be available on, alongside a bundle for two tests at £4.75 and four tests at £9.50.**

Asif Aziz, Director of Healthcare Services at Boots UK, said: “We are pleased to be expanding our COVID-19 testing services even further, with affordablelateral flow testing options for those who still want peace of mind from asymptomatic testing after 1 April.  

“While it is great that we are returning to normal and finding a way to live with COVID-19, we encourage our customers and patients to stay safe and continue to take measures to limit the spread of the virus, especially to those in vulnerable groups.” 

Boots continues to offer a broad range of private COVID-19 testing services, including pre- and post-travel testing. 


*Customers can report results to the UKHSA but cannot use these tests as a verified test for travel requiring a negative antigen test certificate. 

 ** These tests can be bought off the shelves from stores. When purchased via, our standard delivery charges will apply. Delivery is free on where total orders are over £25. For orders under £25 we charge £3.75 for standard delivery, £4.95 for next day delivery. Customers can also collect from store for £1.50 or free if the total order is under £15.


What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.



Take a closer look at our team members and the work they do, learn more about our corporate social responsibility initiatives and see how we work behind the scenes.


Boots is the UK’s leading health and beauty retailer with over 52,000 team members and around 1,900 stores, ranging from local community pharmacies to large destination health and beauty stores.*

Boots serves its customers and patients for life as the leading provider of healthcare on the high street and the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.

2024 marks Boots’ 175th anniversary year. Founder John Boot opened a herbalist store in Nottingham in 1849 to offer an affordable alternative to traditional medicines. His son Jesse expanded the business to become a modern retailer and the biggest chemist in Britain. Throughout its history, Boots has listened, learned and innovated, and it continues to challenge itself to improve its products and services every day.

Boots is part of Walgreens Boots Alliance, which is a global leader in pharmacy-led, health and wellbeing retail.  More company information is available on

*Figures accurate as of 31 May 2024